HomeDMKPQ • OTCMKTS
add
DMK Pharmaceuticals Corp
Previous close
$0.00
Market cap
10.00 USD
Avg Volume
2.83K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Revenue | 9.06K | — |
Operating expense | 2.82M | — |
Net income | -1.39M | — |
Net profit margin | -15.32K | — |
Earnings per share | — | — |
EBITDA | -3.08M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.66M | — |
Total assets | 8.96M | — |
Total liabilities | 13.92M | — |
Total equity | -4.96M | — |
Shares outstanding | 10.09M | — |
Price to book | -0.00 | — |
Return on assets | -114.84% | — |
Return on capital | 97.99% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Net income | -1.39M | — |
Cash from operations | -3.74M | — |
Cash from investing | 1.77M | — |
Cash from financing | 7.96M | — |
Net change in cash | 5.99M | — |
Free cash flow | -1.64M | — |
About
Founded
2006
Website
Employees
12
